U.S. flag

An official website of the United States government

NM_001165963.4(SCN1A):c.1186G>A (p.Gly396Arg) AND Severe myoclonic epilepsy in infancy

Germline classification:
Pathogenic (1 submission)
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003314358.1

Allele description [Variation Report for NM_001165963.4(SCN1A):c.1186G>A (p.Gly396Arg)]

NM_001165963.4(SCN1A):c.1186G>A (p.Gly396Arg)

Gene:
SCN1A:sodium voltage-gated channel alpha subunit 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q24.3
Genomic location:
Preferred name:
NM_001165963.4(SCN1A):c.1186G>A (p.Gly396Arg)
HGVS:
  • NC_000002.12:g.166046961C>T
  • NG_011906.1:g.31679G>A
  • NM_001165963.4:c.1186G>AMANE SELECT
  • NM_001165964.3:c.1186G>A
  • NM_001202435.3:c.1186G>A
  • NM_001353948.2:c.1186G>A
  • NM_001353949.2:c.1186G>A
  • NM_001353950.2:c.1186G>A
  • NM_001353951.2:c.1186G>A
  • NM_001353952.2:c.1186G>A
  • NM_001353954.2:c.1186G>A
  • NM_001353955.2:c.1186G>A
  • NM_001353957.2:c.1186G>A
  • NM_001353958.2:c.1186G>A
  • NM_001353960.2:c.1186G>A
  • NM_001353961.2:c.-1240G>A
  • NM_006920.6:c.1186G>A
  • NP_001159435.1:p.Gly396Arg
  • NP_001159436.1:p.Gly396Arg
  • NP_001189364.1:p.Gly396Arg
  • NP_001340877.1:p.Gly396Arg
  • NP_001340878.1:p.Gly396Arg
  • NP_001340879.1:p.Gly396Arg
  • NP_001340880.1:p.Gly396Arg
  • NP_001340881.1:p.Gly396Arg
  • NP_001340883.1:p.Gly396Arg
  • NP_001340884.1:p.Gly396Arg
  • NP_001340886.1:p.Gly396Arg
  • NP_001340887.1:p.Gly396Arg
  • NP_001340889.1:p.Gly396Arg
  • NP_008851.3:p.Gly396Arg
  • NP_008851.3:p.Gly396Arg
  • LRG_8t1:c.1186G>A
  • LRG_8:g.31679G>A
  • LRG_8p1:p.Gly396Arg
  • NC_000002.11:g.166903471C>T
  • NM_006920.4:c.1186G>A
  • NR_148667.2:n.1572G>A
Protein change:
G396R
Molecular consequence:
  • NM_001353961.2:c.-1240G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001165963.4:c.1186G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001165964.3:c.1186G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001202435.3:c.1186G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353948.2:c.1186G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353949.2:c.1186G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353950.2:c.1186G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353951.2:c.1186G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353952.2:c.1186G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353954.2:c.1186G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353955.2:c.1186G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353957.2:c.1186G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353958.2:c.1186G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353960.2:c.1186G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006920.6:c.1186G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_148667.2:n.1572G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Severe myoclonic epilepsy in infancy (DRVT)
Synonyms:
Epilepsy, Myoclonic, Infantile, Severe; Dravet syndrome; Epileptic encephalopathy, early infantile, 6 (Dravet syndrome); See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0100135; MedGen: C0751122; Orphanet: 33069; OMIM: 607208

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV0040136373billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicunknownclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Development and Validation of a Prediction Model for Early Diagnosis of SCN1A-Related Epilepsies.

Brunklaus A, Pérez-Palma E, Ghanty I, Xinge J, Brilstra E, Ceulemans B, Chemaly N, de Lange I, Depienne C, Guerrini R, Mei D, Møller RS, Nabbout R, Regan BM, Schneider AL, Scheffer IE, Schoonjans AS, Symonds JD, Weckhuysen S, Kattan MW, Zuberi SM, Lal D.

Neurology. 2022 Mar 15;98(11):e1163-e1174. doi: 10.1212/WNL.0000000000200028. Epub 2022 Jan 24.

PubMed [citation]
PMID:
35074891
PMCID:
PMC8935441

SCN1A mutational analysis in Korean patients with Dravet syndrome.

Lim BC, Hwang H, Chae JH, Choi JE, Hwang YS, Kang SH, Ki CS, Kim KJ.

Seizure. 2011 Dec;20(10):789-94. doi: 10.1016/j.seizure.2011.08.002. Epub 2011 Aug 24.

PubMed [citation]
PMID:
21868258
See all PubMed Citations (4)

Details of each submission

From 3billion, SCV004013637.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (4)

Description

The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.96; 3Cnet: 1.00). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with SCN1A related disorder (PMID: 35087721). The variant has been previously reported as de novo in a similarly affected individual (PMID: 35087721). Different missense changes at the same codon (p.Gly396Glu, p.Gly396Trp) have been reported to be associated with SCN1A related disorder (PMID: 21868258, 35074891). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Sep 29, 2024